(Q27852954)

English

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

scientific article

  • Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib

Statements

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib (English)
1 reference
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Nikhil Wagle
0 references
Brian C Grabiner
0 references
Eliezer M Van Allen
0 references
Susanna Jacobus
0 references
Jeffrey G Supko
0 references
Michelle Stewart
0 references
James M Cleary
0 references
Aymen A Elfiky
0 references
Edward C Stack
0 references
Sabina Signoretti
0 references
Geoffrey I Shapiro
0 references
David M Sabatini
0 references
May 2014
0 references
4
0 references
546-53
0 references
5
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit